DocuSign, Inc. (NASDAQ:DOCU) Shares Sold by Claro Advisors LLC

Claro Advisors LLC decreased its position in DocuSign, Inc. (NASDAQ:DOCU) by 21.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,962 shares of the company’s stock after selling 831 shares during the period. Claro Advisors LLC’s holdings in DocuSign were worth $266,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the company. Thrivent Financial for Lutherans acquired a new stake in DocuSign in the 2nd quarter valued at $115,795,000. Pacer Advisors Inc. grew its position in shares of DocuSign by 77.9% in the second quarter. Pacer Advisors Inc. now owns 3,519,969 shares of the company’s stock valued at $188,318,000 after purchasing an additional 1,541,816 shares during the period. KBC Group NV grew its position in shares of DocuSign by 209.8% in the third quarter. KBC Group NV now owns 1,156,874 shares of the company’s stock valued at $71,830,000 after purchasing an additional 783,419 shares during the period. Skandinaviska Enskilda Banken AB publ increased its stake in shares of DocuSign by 151.3% during the second quarter. Skandinaviska Enskilda Banken AB publ now owns 865,872 shares of the company’s stock worth $46,324,000 after purchasing an additional 521,292 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec raised its position in shares of DocuSign by 42.4% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,459,580 shares of the company’s stock worth $90,625,000 after purchasing an additional 434,312 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Price Performance

NASDAQ:DOCU opened at $91.34 on Thursday. The company’s 50-day moving average is $87.95 and its two-hundred day moving average is $69.61. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86. The firm has a market capitalization of $18.45 billion, a price-to-earnings ratio of 18.83, a PEG ratio of 8.70 and a beta of 0.88.

Insider Activity at DocuSign

In related news, CFO Blake Jeffrey Grayson sold 15,588 shares of the firm’s stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $97.78, for a total transaction of $1,524,194.64. Following the completion of the sale, the chief financial officer now directly owns 85,851 shares of the company’s stock, valued at approximately $8,394,510.78. This trade represents a 15.37 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Robert Chatwani sold 14,800 shares of the company’s stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $97.76, for a total transaction of $1,446,848.00. Following the completion of the transaction, the insider now directly owns 73,414 shares in the company, valued at $7,176,952.64. The trade was a 16.78 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 693,537 shares of company stock worth $66,575,817. Insiders own 1.66% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Wells Fargo & Company lifted their price objective on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Friday, December 6th. Morgan Stanley lifted their price target on DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a research note on Friday, December 6th. Piper Sandler increased their price objective on DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. HSBC reaffirmed a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Finally, Robert W. Baird increased their target price on shares of DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, DocuSign presently has an average rating of “Hold” and an average price target of $92.45.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.